UY26170A1 - ANTIGEN (C42) ASSOCIATED WITH TUMORS - Google Patents
ANTIGEN (C42) ASSOCIATED WITH TUMORSInfo
- Publication number
- UY26170A1 UY26170A1 UY26170A UY26170A UY26170A1 UY 26170 A1 UY26170 A1 UY 26170A1 UY 26170 A UY26170 A UY 26170A UY 26170 A UY26170 A UY 26170A UY 26170 A1 UY26170 A1 UY 26170A1
- Authority
- UY
- Uruguay
- Prior art keywords
- antigen
- tumors
- immunotherapy
- encode
- tumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Antígeno asociado a tumores, péptidos inmunógenos derivados de éste, y moléculas de ADN que lo codifican, así como su utilización en la inmunoterapia de enfermedades de cáncer.Tumor-associated antigen, immunogenic peptides derived from it, and DNA molecules that encode it, as well as its use in the immunotherapy of cancer diseases.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19924199A DE19924199A1 (en) | 1999-05-27 | 1999-05-27 | Tumor Associated Antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26170A1 true UY26170A1 (en) | 2000-12-29 |
Family
ID=7909293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26170A UY26170A1 (en) | 1999-05-27 | 2000-05-26 | ANTIGEN (C42) ASSOCIATED WITH TUMORS |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1183349A1 (en) |
JP (1) | JP2003501025A (en) |
AR (1) | AR024114A1 (en) |
AU (1) | AU4924000A (en) |
CA (1) | CA2376133A1 (en) |
CO (1) | CO5280140A1 (en) |
DE (1) | DE19924199A1 (en) |
MX (1) | MXPA01012012A (en) |
UY (1) | UY26170A1 (en) |
WO (1) | WO2000073438A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338937B2 (en) * | 1997-11-17 | 2008-03-04 | Cornell Research Foundation, Inc. | Calcium-activated chloride channel proteins and their use in anti-metastatic therapy |
US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US7049063B2 (en) | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
US7141365B2 (en) * | 2001-05-18 | 2006-11-28 | Syntex (U.S.A.) Llc | Methods for diagnosing a mucin production associated disease condition |
DE60238864D1 (en) | 2001-11-07 | 2011-02-17 | Mankind Corp | FOR EPITOPES OF ANTIGENIC ENCODING EXPRESSION VECTORS AND METHOD FOR THEIR DESIGN |
US20050221350A1 (en) | 2002-05-29 | 2005-10-06 | Toni Weinschenk | Method for identifying immunoreactive peptides |
DE102005041616B4 (en) * | 2005-09-01 | 2011-03-17 | Johannes-Gutenberg-Universität Mainz | Melanoma associated MHC class I associated oligopeptides and polynucleotides encoding them and their uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE345387T1 (en) * | 1998-03-18 | 2006-12-15 | Corixa Corp | COMPOUNDS AND METHODS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER |
WO2000012711A2 (en) * | 1998-09-02 | 2000-03-09 | Incyte Pharmaceuticals, Inc. | Human membrane channel proteins |
-
1999
- 1999-05-27 DE DE19924199A patent/DE19924199A1/en not_active Withdrawn
-
2000
- 2000-05-19 MX MXPA01012012A patent/MXPA01012012A/en unknown
- 2000-05-19 EP EP00931244A patent/EP1183349A1/en not_active Withdrawn
- 2000-05-19 WO PCT/EP2000/004533 patent/WO2000073438A1/en not_active Application Discontinuation
- 2000-05-19 CA CA002376133A patent/CA2376133A1/en not_active Abandoned
- 2000-05-19 AU AU49240/00A patent/AU4924000A/en not_active Abandoned
- 2000-05-19 JP JP2001500751A patent/JP2003501025A/en active Pending
- 2000-05-25 CO CO00038722A patent/CO5280140A1/en not_active Application Discontinuation
- 2000-05-26 AR ARP000102577A patent/AR024114A1/en unknown
- 2000-05-26 UY UY26170A patent/UY26170A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000073438A1 (en) | 2000-12-07 |
AU4924000A (en) | 2000-12-18 |
EP1183349A1 (en) | 2002-03-06 |
MXPA01012012A (en) | 2002-06-21 |
JP2003501025A (en) | 2003-01-14 |
CA2376133A1 (en) | 2000-12-07 |
DE19924199A1 (en) | 2000-11-30 |
CO5280140A1 (en) | 2003-05-30 |
AR024114A1 (en) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
MXPA05008128A (en) | Survivin-derived peptides and use thereof. | |
AU2003242305A1 (en) | Hla-a24-restricted cancer antigen peptide | |
WO1998037093A3 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
AR006250A1 (en) | COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF PROSTATIC CANCER | |
BR9908823A (en) | Lung cancer therapy and diagnosis compounds and processes | |
CY1108960T1 (en) | CRIPTO EXCLUSION COTTAGES AND THEIR USES | |
IL163902A0 (en) | Antibodies against cancer antigen tmeff2 and uses thereof | |
WO2004050707A3 (en) | Tumor-specific recognition molecules | |
MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
CY1111147T1 (en) | TRANSMISSIONAL CYCLE TRANSMISSIONAL LIGGIN ANTIGEN IN HUMAN PROTECTOR AND HIS USE | |
ATE347904T1 (en) | CANCER IMMUNOTHERAPY AND CANCER DIAGNOSIS USING UNIVERSAL TUMOR-ASSOCIATED ANTIGENS INCLUDING HTERT | |
WO2003050243A3 (en) | Novel genes encoding colon cancer antigens | |
BR0306715A (en) | Methods for diagnosis and treatment of tumors | |
EP1708751A4 (en) | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells | |
MXPA05008794A (en) | Glycorpotein antigen sima135 expressed in metastatic human tumor cells. | |
UY26266A1 (en) | ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164 | |
DK1082423T3 (en) | Cyclin E2 genes and proteins | |
UY26170A1 (en) | ANTIGEN (C42) ASSOCIATED WITH TUMORS | |
WO2005099361A3 (en) | MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN | |
IL207012A0 (en) | Diagnosis and therapy of cancer using sgp28-related molecules | |
ATE525401T1 (en) | MHC CLASS I AND II PEPTIDE ANTIGENS DERIVED FROM TUMOR ANTIGEN 5T4 | |
AR023794A1 (en) | ANTIGEN ASSOCIATED WITH TUMORS | |
UY26127A1 (en) | ANTIGEN ASSOCIATED WITH TUMORS | |
ATE528392T1 (en) | NEW PROTEIN AND ITS DNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20100427 |